Literature DB >> 2823148

Relation of HTLV-4 to simian and human immunodeficiency-associated viruses.

B H Hahn1, L I Kong, S W Lee, P Kumar, M E Taylor, S K Arya, G M Shaw.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is the aetiologic agent of AIDS (acquired immune deficiency syndrome) in most countries and probably originated in Central Africa like the AIDS epidemic itself. Evidence for a second major group of human immunodeficiency-associated retroviruses came from a report that West African human populations like wild-caught African green monkeys had serum antibodies that reacted more strongly with a simian immunodeficiency virus (STLV-3Mac) (ref.6) than with HIV-1. Novel T-lymphotropic retroviruses were reported to have been isolated from healthy Senegalese West Africans (HTLV-4) (ref. 4) and from African green monkeys (STLV-3AGM) (ref. 7), and a different retrovirus (HIV-2) was identified in other West African AIDS patients. Genomic analysis of HIV-2 clearly distinguished it from STLV-3 (ref. 9), but restriction enzyme site-mapping of three different HTLV-4 isolates and six different STLV-3AGM isolates showed them to be essentially indistinguishable. In this report we clone, restriction map, and partially sequence three isolates of HTLV-4 (PK82, PK289, PK190) (ref. 4). We find that these viruses differ in nucleotide sequence from each other and from three isolates of STLV-3AGM (K78, K6W, K1) (ref. 7) by 1% or less. We also report the isolation of a T-lymphotropic retrovirus from the peripheral blood of a healthy Senegalese woman which hybridizes preferentially to HIV-2 specific DNA probes. We conclude that HTLV-4 (ref. 4) and STLV-3AGM (ref. 7) are not independent virus isolates and that HIV-2 is present in Senegal as it is in other West African countries.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823148     DOI: 10.1038/330184a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.

Authors:  M G Anderson; J E Clements
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  cis-acting elements in the U3 region of a simian immunodeficiency virus.

Authors:  B Renjifo; N A Speck; S Winandy; N Hopkins; Y Li
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC.

Authors:  J C Kappes; C D Morrow; S W Lee; B A Jameson; S B Kent; L E Hood; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells.

Authors:  T M Niederman; W Hu; L Ratner
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.

Authors:  S K Arya; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Simian immunodeficiency virus from African green monkeys.

Authors:  M D Daniel; Y Li; Y M Naidu; P J Durda; D K Schmidt; C D Troup; D P Silva; J J MacKey; H W Kestler; P K Sehgal
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.

Authors:  T A Rizvi; A T Panganiban
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.

Authors:  K Zingler; D R Littman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.

Authors:  J A Hoxie; B S Haggarty; S E Bonser; J L Rackowski; H Shan; P J Kanki
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.